WallStSmart

Diebold Nixdorf, Incorporated (DBD)vsShopify Inc (SHOP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Shopify Inc generates 221% more annual revenue ($12.37B vs $3.86B). SHOP leads profitability with a 10.8% profit margin vs 2.8%. DBD trades at a lower P/E of 28.0x. DBD earns a higher WallStSmart Score of 56/100 (C).

DBD

Buy

56

out of 100

Grade: C

Growth: 7.0Profit: 5.5Value: 5.3Quality: 5.0

SHOP

Buy

50

out of 100

Grade: C-

Growth: 7.3Profit: 7.0Value: 4.7Quality: 8.5
Piotroski: 3/9Altman Z: 6.60
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for DBD.

SHOPUndervalued (+18.7%)

Margin of Safety

+18.7%

Fair Value

$143.76

Current Price

$118.71

$25.05 discount

UndervaluedFair: $143.76Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

DBD2 strengths · Avg: 9.0/10
EPS GrowthGrowth
815.0%10/10

Earnings expanding 815.0% YoY

Price/BookValuation
2.8x8/10

Reasonable price relative to book value

SHOP4 strengths · Avg: 9.8/10
Revenue GrowthGrowth
34.3%10/10

Revenue surging 34.3% year-over-year

Debt/EquityHealth
0.0110/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
6.6010/10

Safe zone — low bankruptcy risk

Market CapQuality
$142.72B9/10

Large-cap with strong market position

Areas to Watch

DBD2 concerns · Avg: 3.5/10
P/E RatioValuation
28.0x4/10

Moderate valuation

Profit MarginProfitability
2.8%3/10

2.8% margin — thin

SHOP4 concerns · Avg: 3.3/10
PEG RatioValuation
2.104/10

Expensive relative to growth rate

Price/BookValuation
12.4x4/10

Trading at 12.4x book value

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

P/E RatioValuation
107.8x2/10

Premium valuation, high expectations priced in

Comparative Analysis Report

WallStSmart Research

Bull Case : DBD

The strongest argument for DBD centers on EPS Growth, Price/Book.

Bull Case : SHOP

The strongest argument for SHOP centers on Revenue Growth, Debt/Equity, Altman Z-Score. Revenue growth of 34.3% demonstrates continued momentum.

Bear Case : DBD

The primary concerns for DBD are P/E Ratio, Profit Margin. Thin 2.8% margins leave little buffer for downturns.

Bear Case : SHOP

The primary concerns for SHOP are PEG Ratio, Price/Book, Piotroski F-Score. A P/E of 107.8x leaves little room for execution misses.

Key Dynamics to Monitor

DBD profiles as a value stock while SHOP is a growth play — different risk/reward profiles.

SHOP carries more volatility with a beta of 2.64 — expect wider price swings.

SHOP is growing revenue faster at 34.3% — sustainability is the question.

Monitor SOFTWARE - APPLICATION industry trends, competitive dynamics, and regulatory changes.

Bottom Line

DBD scores higher overall (56/100 vs 50/100). SHOP offers better value entry with a 18.7% margin of safety. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Diebold Nixdorf, Incorporated

TECHNOLOGY · SOFTWARE - APPLICATION · USA

Diebold Nixdorf, Incorporated provides connected commerce solutions to financial institutions and retailers in Western Europe, Eastern Europe, Asia, the Middle East, Africa, the United States, Canada, Mexico and Latin America. The company is headquartered in North Canton, Ohio.

Shopify Inc

TECHNOLOGY · SOFTWARE - APPLICATION · USA

Shopify Inc., a commerce company, offers a commerce and service platform in Canada, the United States, the United Kingdom, Australia, Latin America, and internationally. The company is headquartered in Ottawa, Canada.

Want to dig deeper into these stocks?